Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAPDAP and Artesunate for Malaria
NCT00519467Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2003
- Primary completion
- Feb 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of artesunate in Malaria, sponsored by GSK. Started Jun 2003; status: completed.
02
Drugs
artesunate
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT00519467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519467.